Congressional disclosures
| Office | Representative (NC-6) |
|---|---|
| Disclosed events | 25 |
| Purchases, all years | 15 |
| Sales | 8 |
| Publicly available | Transaction date | Asset | Action | Owner | Reported amount |
|---|---|---|---|---|---|
| 2014-10-17 | 2014-10-16 | Acordia Therapeutics, Inc (in UBS CMA) | purchase | not_indicated | A $1,000- $15,000 |
| 2014-09-02 | 2014-08-29 | CBI | purchase | not_indicated | A $1,000- $15,000 |
| 2014-09-02 | 2014-08-29 | PF | sale | not_indicated | A $1,000- $15,000 |
| 2014-09-02 | 2014-08-29 | WETF | sale | not_indicated | A $1,000- $15,000 |
| 2014-07-30 | 2014-07-28 | PF | purchase | not_indicated | A $1,000- $15,000 |
| 2014-07-30 | 2014-07-28 | WETF | purchase | not_indicated | A $1,000- $15,000 |
| 2014-07-30 | 2014-07-28 | EBAY | sale | not_indicated | A $1,000- $15,000 |
| 2014-07-11 | 2014-07-10 | GRPN | purchase | not_indicated | A $1,000- $15,000 |
| 2014-07-11 | 2014-07-01 | Activis Plc (in UBS CMA) | exchange | not_indicated | A $1,000- $15,000 |
| 2014-07-11 | 2014-07-01 | Forest Laboratories (merged with Activis) | exchange | not_indicated | A $1,000- $15,000 |
| 2014-07-07 | 2014-06-27 | AAPL | purchase | not_indicated | A $1,000- $15,000 |
| 2014-07-07 | 2014-06-27 | EBAY | purchase | not_indicated | A $1,000- $15,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.